eFFECTOR Therapeutics, Inc. (EFTR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -29.55 Million | -25.89 Million | -24.88 Million | 13.83 Million | -27.59 Million |
| Net Income | -35.81 Million | -22.66 Million | 15.79 Million | 14.21 Million | -29.73 Million |
| Depreciation & Amortization | 111 Thousand | 53 Thousand | 24 Thousand | 160 Thousand | 307 Thousand |
| Deferred income taxes | -855 Thousand | - | -539 Thousand | -333 Thousand | -1.98 Million |
| Stock-based compensation | 4.59 Million | 5.33 Million | 8.66 Million | 499 Thousand | 646 Thousand |
| Change in working capital | 1.68 Million | 2.67 Million | -238 Thousand | -824 Thousand | 1.07 Million |
| Other non-cash items | 725 Thousand | -11.29 Million | -48.59 Million | 122 Thousand | 2.1 Million |
| Investing Cash Flow | 14.48 Million | -17.86 Million | 565 Thousand | -154 Thousand | 84 Thousand |
| Investments in PPE | -97 Thousand | -192 Thousand | -42 Thousand | -154 Thousand | -4000.00 |
| Acquisitions | -14.58 Million | 17.66 Million | 607 Thousand | - | 88 Thousand |
| Investment purchases | -17.16 Million | -52.41 Million | - | - | - |
| Sales/Maturities of investments | 31.75 Million | 34.75 Million | - | - | - |
| Other Investing Activities | 14.58 Million | -17.66 Million | 607 Thousand | - | 88 Thousand |
| Financing Cash Flow | 21.23 Million | 2.76 Million | 58.8 Million | -1.89 Million | 20.24 Million |
| Debt repayment | - | - | -13.94 Million | -2 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -86 Thousand |
| Common Stock Issuance | 21.23 Million | 2.79 Million | 56 Thousand | 108 Thousand | 20.32 Million |
| Other Financing Activities | 6.71 Million | -34 Thousand | 72.69 Million | -1.89 Million | 20.32 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 855 Thousand | 958 Thousand | 155 Thousand | -251 Thousand | -727 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 830 Thousand | 1.71 Million | -393 Thousand | -573 Thousand | 1.79 Million |
| Cash at beginning of period | 8.7 Million | 49.7 Million | 15.21 Million | 3.42 Million | - |
| Cash at end of period | 14.87 Million | 8.7 Million | 49.7 Million | 15.21 Million | 3.42 Million |
| Capital Expenditure | -97 Thousand | -192 Thousand | -42 Thousand | -154 Thousand | -4000.00 |
| Effect of forex changes on cash | - | - | - | - | 10.69 Million |
| Net cash flow / Change in cash | 6.16 Million | -40.99 Million | 34.48 Million | 11.78 Million | 3.42 Million |
| Free Cash Flow | -29.64 Million | -26.09 Million | -24.93 Million | 13.68 Million | -27.6 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.83 Million | -9.12 Million | -35.81 Million | -8.3 Million | -8.36 Million | -10.01 Million |
| Depreciation & Amortization | 28 Thousand | 30 Thousand | 111 Thousand | 26 Thousand | 27 Thousand | 28 Thousand |
| Deferred income taxes | - | 63 Thousand | -855 Thousand | -175 Thousand | -78 Thousand | - |
| Stock-based compensation | 1.01 Million | 1.12 Million | 4.59 Million | 1.14 Million | 1.16 Million | 1.16 Million |
| Change in working capital | 479 Thousand | 2.42 Million | 1.68 Million | -521 Thousand | -1.43 Million | 1.21 Million |
| Other non-cash items | 1.82 Million | -82 Thousand | 725 Thousand | 76 Thousand | 93 Thousand | -28 Thousand |
| Investing Cash Flow | -6.32 Million | 8.94 Million | 14.48 Million | -1.91 Million | -1.57 Million | 9.02 Million |
| Investments in PPE | - | -54 Thousand | -97 Thousand | -2000.00 | -28 Thousand | -13 Thousand |
| Acquisitions | - | 5.58 Million | -14.58 Million | 1.91 Million | 1.54 Million | -9.04 Million |
| Investment purchases | -9.82 Million | - | -17.16 Million | -3.91 Million | -10.29 Million | -2.96 Million |
| Sales/Maturities of investments | 3.5 Million | 9 Million | 31.75 Million | 2 Million | 8.75 Million | 12 Million |
| Other Investing Activities | -6.32 Million | 9 Million | 14.58 Million | -1.91 Million | -1.54 Million | 9.04 Million |
| Financing Cash Flow | 14.23 Million | 6.1 Million | 21.23 Million | 342 Thousand | 14.57 Million | 212 Thousand |
| Debt repayment | -556 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.78 Million | 6.1 Million | 21.23 Million | 324 Thousand | 14.53 Million | 212 Thousand |
| Other Financing Activities | 14.78 Million | 6.1 Million | 6.71 Million | 18 Thousand | 38 Thousand | 212 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -716 Thousand | 1.24 Million | 855 Thousand | -332 Thousand | -2.28 Million | 2.22 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.19 Million | 1.18 Million | 830 Thousand | -189 Thousand | 853 Thousand | -1.01 Million |
| Cash at beginning of period | 14.87 Million | 5.38 Million | 8.7 Million | 14.71 Million | 10.31 Million | 8.7 Million |
| Cash at end of period | 15.5 Million | 14.87 Million | 14.87 Million | 5.38 Million | 14.71 Million | 10.31 Million |
| Capital Expenditure | - | -54 Thousand | -97 Thousand | -2000.00 | -28 Thousand | -13 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 633 Thousand | 9.48 Million | 6.16 Million | -9.32 Million | 4.4 Million | 1.6 Million |
| Free Cash Flow | -7.27 Million | -5.62 Million | -29.64 Million | -7.75 Million | -8.62 Million | -7.65 Million |
1979
FOXF
MTPP
OILCOUNTUB
8291
KENFIN